Hormone Sensitive Prostate Cancer Patients Switched to Degarelix Therapy After Failing on GnRH Agonists (DELAY)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2012 by CMX Research.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Ferring Pharmaceuticals
Information provided by (Responsible Party):
CMX Research
ClinicalTrials.gov Identifier:
NCT01366053
First received: May 30, 2011
Last updated: February 2, 2012
Last verified: February 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2014
  Estimated Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)